PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to heal painful, Hard-to-Treat skin wounds
Disease control TerminatedThis study tested whether the drug vilobelimab could help heal painful, open skin ulcers caused by a rare condition called pyoderma gangrenosum. About 54 adults with at least one qualifying ulcer received either the drug or a placebo. The main goal was to see if the drug could le…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE3 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Early-Stop trial tests new drug for painful, disfiguring skin sores
Disease control TerminatedThis study aimed to see if a drug called spesolimab could help heal severe, painful skin ulcers caused by a rare autoimmune condition called pyoderma gangrenosum. The drug, given by infusion every few weeks, works by blocking a specific part of the immune system thought to drive …
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Skin graft trial seeks to heal devastating wounds
Disease control TerminatedThis study tested a treatment called EpiFix, a special tissue graft, to help heal painful, non-healing skin ulcers caused by a condition called pyoderma gangrenosum. Researchers also aimed to understand how the graft works by studying genetic changes in the wound. The trial invol…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE4 • Sponsor: Louisiana State University Health Sciences Center in New Orleans • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC